Meeder Asset Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31K | Buy |
+18
| New | +$2.31K | ﹤0.01% | 805 |
|
|
2025
Q1 | – | Sell |
-48
| Closed | -$4.19K | – | 916 |
|
|
2024
Q4 | $4.19K | Buy |
48
+2
| +4% | +$174 | ﹤0.01% | 852 |
|
|
2024
Q3 | $4.26K | Buy |
46
+16
| +53% | +$1.48K | ﹤0.01% | 770 |
|
|
2024
Q2 | $3.23K | Sell |
30
-1
| -3% | -$108 | ﹤0.01% | 818 |
|
|
2024
Q1 | $2.94K | Buy |
+31
| New | +$2.94K | ﹤0.01% | 696 |
|
|
2021
Q4 | – | Sell |
-2,227
| Closed | -$231K | – | 1311 |
|
|
2021
Q3 | $231K | Hold |
2,227
| – | – | 0.01% | 677 |
|
|
2021
Q2 | $196K | Sell |
2,227
-19
| -0.8% | -$1.67K | 0.01% | 728 |
|
|
2021
Q1 | $218K | Buy |
+2,246
| New | +$218K | 0.01% | 703 |
|
|
2020
Q4 | – | Sell |
-1,278
| Closed | -$118K | – | 1900 |
|
|
2020
Q3 | $118K | Buy |
1,278
+360
| +39% | +$33.2K | 0.01% | 738 |
|
|
2020
Q2 | $73K | Buy |
918
+748
| +440% | +$59.5K | ﹤0.01% | 841 |
|
|
2020
Q1 | $10K | Buy |
170
+168
| +8,400% | +$9.88K | ﹤0.01% | 1507 |
|
|
2019
Q4 | $0 | Sell |
2
-92
| -98% | – | ﹤0.01% | 2252 |
|
|
2019
Q3 | $7K | Hold |
94
| – | – | ﹤0.01% | 1634 |
|
|
2019
Q2 | $9K | Hold |
94
| – | – | ﹤0.01% | 1478 |
|
|
2019
Q1 | $8K | Hold |
94
| – | – | ﹤0.01% | 1293 |
|
|
2018
Q4 | $5K | Hold |
94
| – | – | ﹤0.01% | 1398 |
|
|
2018
Q3 | $7K | Sell |
94
-207
| -69% | -$15.4K | ﹤0.01% | 1238 |
|
|
2018
Q2 | $19.1K | Buy |
301
+42
| +16% | +$2.67K | ﹤0.01% | 969 |
|
|
2018
Q1 | $24K | Buy |
259
+30
| +13% | +$2.78K | ﹤0.01% | 846 |
|
|
2017
Q4 | $18K | Buy |
229
+181
| +377% | +$14.2K | ﹤0.01% | 950 |
|
|
2017
Q3 | $3K | Buy |
48
+5
| +12% | +$313 | ﹤0.01% | 1364 |
|
|
2017
Q2 | $2K | Buy |
43
+5
| +13% | +$233 | ﹤0.01% | 1386 |
|
|
2017
Q1 | $2K | Buy |
+38
| New | +$2K | ﹤0.01% | 1349 |
|